Jasper Therapeutics to Present Data on Briquilimab in Mast Cell Driven Diseases at the EAACI Congress 2024
May 30, 2024 18:05 ET
|
Jasper Therapeutics, Inc.
REDWOOD CITY, Calif., May 30, 2024 (GLOBE NEWSWIRE) -- Jasper Therapeutics, Inc. (Nasdaq: JSPR) (Jasper), a clinical stage biotechnology company focused on development of briquilimab, a novel...
QIAGEN and Myriad Genetics develop distributable homologous recombination deficiency test for global research and companion diagnostics applications
May 30, 2024 17:55 ET
|
Myriad Genetics, Inc.
Next-generation-sequencing-based homologous recombination deficiency (HRD) assay based on QIAGEN’s QIAseq xHYB technology, QIAGEN Digital Insight solutions, and Myriad’s proprietary, FDA-approved...
Plug to Webcast Annual Shareholder Meeting on June 5, 2024
May 30, 2024 17:55 ET
|
Plug Power, Inc.
LATHAM, N.Y., May 30, 2024 (GLOBE NEWSWIRE) -- Plug Power Inc. (NASDAQ: PLUG), a global leader in comprehensive hydrogen solutions for the green hydrogen economy, invites investors and the general...
HashiCorp Announces First Quarter of Fiscal Year 2025 Financial Results
May 30, 2024 17:50 ET
|
HashiCorp, Inc.
HashiCorp Announces First Quarter of Fiscal Year 2025 Financial Results
Oak Valley Bancorp Honored with the 2023 Raymond James Community Bankers Cup Award
May 30, 2024 17:49 ET
|
Oak Valley Community Bank
OAKDALE, Calif., May 30, 2024 (GLOBE NEWSWIRE) -- Oak Valley Bancorp (NASDAQ: OVLY), the parent company of Oak Valley Community Bank, has been awarded the 2023 Raymond James Community Bankers Cup as...
Sotera Health Announces Closing of $1.5 Billion Term Loan B and $750 Million Senior Secured Note Financings
May 30, 2024 17:12 ET
|
Sotera Health Services, LLC
CLEVELAND, May 30, 2024 (GLOBE NEWSWIRE) -- Sotera Health Company (“Sotera Health” or the “Company”) (Nasdaq: SHC), a leading global provider of mission-critical end-to-end sterilization solutions...
Biogen Receives European Commission Approval for QALSODY® (tofersen), the First Therapy to Treat a Rare, Genetic Form of ALS
May 30, 2024 16:51 ET
|
Biogen Inc.
SOD1-ALS is a devastating, uniformly fatal, and ultra-rare genetic form of ALS estimated to affect less than 1,000 people in Europe1QALSODY is Biogen’s third rare disease therapy to be approved in the...
BurgerFi to Consider Strategic Alternatives
May 30, 2024 16:51 ET
|
BurgerFi International
Designates David Heidecorn as successor to Ophir Sternberg as Chairman of the Board Enters retention agreements with executive leadership to ensure steady leadership FORT LAUDERDALE,...
Favorable Oncocyte VitaGraft Kidney Study Results Published in the New England Journal of Medicine
May 30, 2024 16:47 ET
|
OncoCyte Corporation
Late-breaking presentation of data at American Transplant Congress on Monday, June 3Data show potential to monitor for therapeutic efficacy and recurrencePotential repeat testing opportunities with...
SAB Biotherapeutics Announces Departure of Chief Financial Officer
May 30, 2024 16:45 ET
|
SAB Biotherapeutics, Inc.
MIAMI, May 30, 2024 (GLOBE NEWSWIRE) -- SAB Biotherapeutics (Nasdaq: SABS) (the “Company” or “SAB”), a clinical-stage biopharmaceutical company with a novel immunotherapy platform developing a human...